In the past year, consumer giant Johnson & Johnson has been hit with four jury verdicts totaling about $300 million in cases linking its popular baby powder to ovarian cancer. With each defeat, its lawyers have pledged the fight is not over.
On Wednesday, Johnson & Johnson got its first crack at dismantling one of the verdicts in which Missouri juries have found that its baby powder caused a woman to get ovarian cancer. And a lot rides on how the U.S. Supreme Court rules in Bristol-Myers Squibb v. Superior Court of California, a closely watched case that could clarify the rules of jurisdiction for mass torts claims.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
